Califf Appears To Set 2025 As End Of His Term As US FDA Commissioner

 
• By Derrick Gingery

Outlining what changes he wants to see at the agency before he leaves, Califf also worries congressional inaction on the user fee reauthorization could affect hiring efforts.

Robert Califf at Alliance for a Stronger FDA
FDA Commissioner Robert Califf spoke about a number of subjects during a Q&A session with the Alliance for a Stronger FDA. • Source: Screenshot

More from US FDA

More from Agency Leadership